Unione Europea - sloveno - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - zdravila, ki se uporabljajo pri diabetesu - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. poleg drugimi zdravili za zdravljenje diabetesa tipa 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

Unione Europea - sloveno - EMA (European Medicines Agency)

stada arzneimittel ag - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastična sredstva - oyavas in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. oyavas in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. za nadaljnje informacije o statusu receptorja človeškega epidermičnega rastnega faktorja 2 (her2) glejte poglavje 5. oyavas in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with oyavas in combination with capecitabine. za nadaljnje informacije o statusu her2 glejte poglavje 5. oyavas, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. oyavas, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations (see section 5. oyavas in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. oyavas, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer (see section 5. oyavas, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor–targeted agents. oyavas, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents (see section 5. oyavas, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix (see section 5.

Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stada arzneimittel ag - ibandronska kislina - koncentrat za raztopino za infundiranje - ibandronska kislina 6 mg / 1 viala - ibandronska kislina

Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bayer pharma ag - gadopentetna kislina - raztopina za injiciranje - gadopentetna kislina 274 mg / 1 ml - gadopentetna kislina

Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bayer pharma ag - gadopentetna kislina - raztopina za injiciranje - gadopentetna kislina 274 mg / 1 ml - gadopentetna kislina

Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bayer pharma ag - gadopentetna kislina - raztopina za injiciranje - gadopentetna kislina 274 mg / 1 ml - gadopentetna kislina

Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stada arzneimittel ag - amlodipin, valsartan - filmsko obložena tableta - amlodipin 10 mg / 1 tableta; valsartan 160 mg / 1 tableta - valsartan in amlodipin

Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

helm ag - cinakalcet - filmsko obložena tableta - cinakalcet 60 mg / 1 tableta - cinakalcet

Unione Europea - sloveno - EMA (European Medicines Agency)

bayer pharma ag - regorafenib - kolorektalne neoplazme - antineoplastic agents, protein kinase inhibitors - stivarga je označen kot monotherapy za zdravljenje odraslih bolnikov z:metastatskega kolorektalnega raka (crc), ki so bili predhodno zdravljeni z, ali se ne štejejo kandidati, ki so na voljo terapije - ti vključujejo fluoropyrimidine temeljijo na kemoterapijo, anti-vegf terapije in anti-egfr terapije;unresectable ali metastatskim gastrointestinal stromal tumorjev (bistvo), ki je napredoval na ali so nestrpni, da se pred zdravljenjem z imatinib in sunitinib;hepatocellular carcinoma (hcc), ki so bili predhodno zdravljeni z sorafenib.

Slovenia - sloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

b. braun melsungen ag - cinkov acetat dihidrat; glicin; glukoza, brezvodna; glutaminska kislina; histidin; kalcijev klorid dihidrat; kalijev acetat; alanin; arginin; asparaginska kislina; fenilalanin; izolevcin; levcin; lizin; metionin; prolin; serin; treonin; triptofan; valin; magnezijev acetat tetrahidrat; natrijev acetat trihidrat; natrijev dihidrogenfosfat dihidrat; natrijev hidroksid; sojino olje, rafinirano; trigliceridi omega-3-kislin; trigliceridi, srednjeverižni, nasičeni; natrijev klorid - emulzija za infundiranje - cinkov acetat dihidrat 7,024 mg / 1 vreča  glicin2,312 mg / 1 vreča  glukoza, brezvodna144 mg / 1 vreča  glutaminska kislina4,908 mg / 1 vreča  histidin1,753 mg / 1 vreča  kalcijev klorid dihidrat0,623 mg / 1 vreča  kalijev acetat3,689 mg / 1 vreča  alanin6,792 mg / 1 vreča  arginin3,78 mg / 1 vreča  asparaginska kislina2,1 mg / 1 vreča  fenilalanin4,916 mg / 1 vreča  izolevcin3,284 mg / 1 vreča  levcin4,384 mg / 1 vreča  lizin3,186 mg / 1 vreča  metionin2,736 mg / 1 vreča  prolin4,76 mg / 1 vreča  serin4,2 mg / 1 vreča  treonin2,54 mg / 1 vreča  triptofan0,8 mg / 1 vreča  valin3,604 mg / 1 vreča  magnezijev acetat tetrahidrat0,91 mg / 1 vreča  natrijev acetat trihidrat0,25 mg / 1 vreča  natrijev dihidrogenfosfat dihidrat2,496 mg / 1 vreča  natrijev hidroksid1,171 mg / 1 vreča  sojino olje, rafinirano16 mg / 1 vreča  trigliceridi omega-3-kislin4 mg / 1 vreča  trigliceridi, srednjeverižni, nasičeni20 mg / 1 vreča  natrijev klorid0,378 mg / 1 vreča; glicin 2,312 mg / 1 vreča  glukoza, brezvodna144 mg / 1 vreča  glutaminska kislina4,908 mg / 1 vreča  histidin1,753 mg / 1 vreča  kalcijev klorid dihidrat0,623 mg / 1 vreča  kalijev acetat3,689 mg / 1 vreča  alanin6,792 mg / 1 vreča  arginin3,78 mg / 1 vreča  asparaginska kislina2,1 mg / 1 vreča  fenilalanin4,916 mg / 1 vreča  izolevcin3,284 mg / 1 vreča  levcin4,384 mg / 1 vreča  lizin3,186 mg / 1 vreča  metionin2,736 mg / 1 vreča  prolin4,76 mg / 1 vreča  serin4,2 mg / 1 vreča  treonin2,54 mg / 1 vreča  triptofan0,8 mg / 1 vreča  valin3,604 mg / 1 vreča  magnezijev acetat tetrahidrat0,91 mg / 1 vreča  natrijev acetat trihidrat0,25 mg / 1 vreča  natrijev dihidrogenfosfat dihidrat2,496 mg / 1 vreča  natrijev hidroksid1,171 mg / 1 vreča  sojino olje, rafinirano16 mg / 1 vreč - kombinacije